Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices 
UK Starting Salaries See Strongest Growth in 18 Months as Hiring Sentiment Improves 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out 
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Australian Pension Funds Boost Currency Hedging as Aussie Dollar Strengthens 
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Baby formulas in the United States are going out of stock; thus, the shortage situation is getting worse. Major pharmacy chains have started limiting the sale of infant milk as there is not enough supply to meet the demand.
As per BBC News, the infant milk formula shortages in the U.S. intensified after Abbott nutrition which made the Similac brand issue a recall on the baby formula in February due to contamination.
Abbott is the main supplier of infant formula to a number of state government programs for low-income families, and it shared it is working with regulators so it can re-open its manufacturing plant. The company also said that to deal with the shortage issue, it has been sending additional shipments from a factory in Ireland. In fact, it is expecting double shipments this year.
“We have an FDA-registered plant in Cootehill, Ireland, where we've increased the volume of Similac Advance powder formula produced for the U.S. We are air-shipping product from this facility into the U.S. daily and the product is being restocked regularly,” Abbott previously said in a statement.
The company added, “Our Cootehill team sources ingredients from approximately 1,000 dairy farms in the local area. Following stringent quality and safety processes, each batch of infant formula undergoes extensive quality checks before it reaches stores.”
In any case, CNBC reported that 26 states in the U.S. have run out of baby formula. The out-of-stock rating reportedly reached more than 40% compared to just seven states three weeks before.
Based on this recent rating data, it seems that the baby formula shortage in the country will not be resolved any time soon. Rather, the situation is getting worse as more states are being hit with the shortage.
“Unfortunately, we do not see this slowing down any time soon,” Ben Reich, chief executive officer of Datasembly public data firm, said earlier this week. “Inflation, supply chain shortages and product recalls have continued to bring volatility to the category, and continues to be one of the most affected products in the market.”
Finally, major retail stores and pharmacies, including CVS Health Corp., Walgreens, Target Corp., and Kroger, have all limited the sale of infant formula as the supply is really low, Reuters reported.
